New Weight Loss Implant for Cats: Implant to Replace Diets and Medications.

According to ТСН: The Californian company Okava Pharmaceuticals has started clinical trials for the OKV-119 implant, which will help reduce excess weight in cats. This subcutaneous implant slowly releases the active drug over six months and can significantly improve the quality of life for pets, replacing ineffective diets.

According to research, weight loss medications have long been of interest not only to people but can also become a significant aid for our four-legged friends. Okava Pharmaceuticals has launched clinical studies of the GLP-1 weight control drug for 50 cats, aiming for effective use of the OKV-119 implant.

Potential of the New Implant

The MEOW-1 study is one of the first in this field. As the company notes, the implant is designed to mimic many physiological effects of fasting — improving insulin sensitivity, reducing body fat, and more efficient energy metabolism — without the need to significantly alter feeding regimens or disrupt the bond between humans and animals, which is often based on food.

Approximately 60% of cats in the U.S. are overweight, which increases the risk of developing diabetes and other diseases. Veterinarian and animal weight issues expert Dr. Ernie Ward emphasized:

“In veterinary medicine over the past 100 years, the only prescription has been: feed less, move more — and that simply does not work for all types of obesity.”

Possible Benefits and Challenges

Ward believes that the new implant can be beneficial not only for weight loss but also due to the positive effects that GLP-1 has already demonstrated in humans, including diabetes control and overall health improvement. However, he also notes that there are certain uncertainties, such as cost, potential side effects, and actual effectiveness. Okava states that after receiving approval, the implant may cost around $100 per month for pet owners.

Some cat owners are already paying attention to this potential treatment. Savannah Tilking spoke about her ten-year-old cat weighing 9.5 kg:

“He spends most days asleep. He loves to lounge… a big lover. I think if my vet said: 'He has diabetes. We've tried everything else. We need to consider this option,' then, of course, yes.”

Future Plans

Results from the MEOW-1 study are expected next summer, and the company plans to submit documents for FDA approval of the implant within two years. A similar drug for dogs is also under development.

Furthermore, for the health and activity of an adult cat, it is recommended to feed twice a day — in the morning and evening, which corresponds to their natural biorhythms. Kittens up to six months should eat 4-5 times a day, while pregnant and sick cats may need food 3-4 times a day in small portions; this is best discussed with a veterinarian.

As of today, too many cats are facing weight issues, so the new implant could be an important step towards improving their health. Planned clinical studies will provide more information on the effectiveness of this method, which, in turn, will impact the possibilities for treating obesity in pets.